Published in Biomed Res Int on April 29, 2014
Sorafenib-RT Treatment for Liver Metastasis (SLIM) | NCT00892424
Cancer statistics, 2012. CA Cancer J Clin (2012) 87.38
Systemic therapy for colorectal cancer. N Engl J Med (2005) 8.94
Oligometastases. J Clin Oncol (1995) 4.95
Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg (2005) 4.86
Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol (2009) 4.59
Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study. J Clin Oncol (2005) 3.88
Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys (1995) 3.20
Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol (1995) 3.08
Phase I study of individualized stereotactic body radiotherapy of liver metastases. J Clin Oncol (2009) 2.78
Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg (2004) 2.65
American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer. J Clin Oncol (2009) 2.52
Radiation-associated liver injury. Int J Radiat Oncol Biol Phys (2010) 2.39
Extending the frontiers of surgical therapy for hepatic colorectal metastases: is there a limit? J Clin Oncol (2005) 2.38
Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial. J Clin Oncol (2001) 2.28
Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study. Acta Oncol (2006) 2.16
Solitary colorectal liver metastasis: resection determines outcome. Arch Surg (2006) 2.06
Survival after hepatic resection for colorectal metastases: a 10-year experience. Ann Surg Oncol (2006) 2.02
An overview of hypofractionation and introduction to this issue of seminars in radiation oncology. Semin Radiat Oncol (2008) 1.89
Stereotactic body radiotherapy for colorectal liver metastases: a pooled analysis. Cancer (2011) 1.87
Radiotherapy for liver metastases: a review of evidence. Int J Radiat Oncol Biol Phys (2012) 1.85
Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: the risk factors and hepatic radiation tolerance. Int J Radiat Oncol Biol Phys (2006) 1.85
American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys (2010) 1.78
Stereotactic body radiation therapy: a novel treatment modality. Nat Rev Clin Oncol (2009) 1.76
Stereotactic body radiotherapy for oligometastases. Lancet Oncol (2013) 1.76
Phase II study on stereotactic body radiotherapy of colorectal metastases. Acta Oncol (2006) 1.72
Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases. Int J Radiat Oncol Biol Phys (2006) 1.66
Stereotactic radiotherapy of primary liver cancer and hepatic metastases. Acta Oncol (2006) 1.58
Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma. Clin Transl Oncol (2010) 1.55
Stereotactic body radiation therapy for colorectal liver metastases. Br J Surg (2010) 1.35
Is stereotactic body radiation therapy an attractive option for unresectable liver metastases? A preliminary report from a phase 2 trial. Int J Radiat Oncol Biol Phys (2013) 1.34
Phase I dose-escalation study of stereotactic body radiotherapy in patients with hepatic metastases. Ann Surg Oncol (2010) 1.31
Stereotactic radiotherapy of targets in the lung and liver. Strahlenther Onkol (2001) 1.30
Pattern of recurrence after hepatic resection for colorectal metastases. Br J Surg (1993) 1.29
Image-guided robotic stereotactic body radiation therapy for liver metastases: is there a dose response relationship? Int J Radiat Oncol Biol Phys (2011) 1.26
Review and uses of stereotactic body radiation therapy for oligometastases. Oncologist (2012) 1.25
A rationale for the targeted treatment of oligometastases with radiotherapy. J Surg Oncol (2008) 1.24
Rates and patterns of recurrence for percutaneous radiofrequency ablation and open wedge resection for solitary colorectal liver metastasis. J Gastrointest Surg (2007) 1.19
Colorectal liver metastases: regional chemotherapy via transarterial chemoembolization (TACE) and hepatic chemoperfusion: an update. Eur Radiol (2006) 1.19
Local, intrahepatic, and systemic recurrence patterns after radiofrequency ablation of hepatic malignancies. J Gastrointest Surg (2002) 1.07
Cryotherapy in the treatment of liver metastases from colorectal cancer. Semin Oncol (2002) 1.00
Stereotactic body radiation therapy for patients with heavily pretreated liver metastases and liver tumors. Front Oncol (2012) 0.97
Image-guided robotic stereotactic radiosurgery for unresectable liver metastases: preliminary results. Anticancer Res (2009) 0.95
Experimental and clinical observations on hepatic cryosurgery for colorectal metastases. Cancer Res (1991) 0.93
Single-dose radiosurgical treatment for hepatic metastases--therapeutic outcome of 138 treated lesions from a single institution. Radiat Oncol (2013) 0.92
Patterns of recurrence after curative-intent radiation for oligometastases confined to one organ. Am J Clin Oncol (2010) 0.92